NeuroPace, Inc. (NPCE) Financial Statements

Income statement

Metric	TTM	2025	2024	2023	2022
Revenue
Total Revenue	98.8M	100.0M	79.9M	65.4M	45.5M
Cost of Revenue	20.1M	22.8M	20.8M	17.3M	13.0M
Gross Profit	78.7M	77.2M	59.1M	48.1M	32.5M
Operating Expenses
R&D Expense	27.7M	27.9M	23.7M	20.8M	21.9M
SG&A Expense	66.1M	65.7M	57.1M	54.5M	51.3M
General & Admin Expense	18.8M	19.1M	17.4M	—	—
Selling & Marketing Expense	47.2M	46.6M	39.7M	—	—
Other Expenses	—	—	—	—	—
Total Operating Expenses	93.8M	93.6M	80.8M	75.3M	73.3M
Cost and Expenses	113.9M	116.3M	101.6M	92.6M	86.3M
Operating Income (EBIT)	(15.1M)	(16.3M)	(21.7M)	(27.2M)	(40.8M)
Non-Operating
Interest Income	2.4M	2.8M	3.0M	3.0M	1.6M
Interest Expense	6.3M	7.5M	8.8M	8.5M	7.5M
Net Interest Income	(3.9M)	(4.6M)	(5.8M)	(5.5M)	(6.0M)
Other Non-Op Income/Expense	(4.0M)	(5.1M)	(5.5M)	(5.8M)	(6.3M)
Non-Operating Income (excl Interest)	(1.6M)	(2.3M)	(3.3M)	(2.7M)	(1.2M)
EBT (Pre-Tax Income)	(19.1M)	(21.5M)	(27.1M)	(33.0M)	(47.1M)
Income Tax Expense	—	—	—	—	—
Bottom Line
Net Income	(19.1M)	(21.5M)	(27.1M)	(33.0M)	(47.1M)
Earnings from Cont. Ops	(19.1M)	(21.5M)	(27.1M)	(33.0M)	(47.1M)
Earnings from Discont. Ops	—	—	—	—	—
Bottom Line Net Income	(19.1M)	(21.5M)	(27.1M)	(33.0M)	(47.1M)
Per Share
Basic EPS	($0.57)	($0.66)	($0.93)	($1.27)	($1.91)
Diluted EPS	($0.57)	($0.66)	($0.93)	($1.27)	($1.91)
Revenue Per Share	$2.90	$3.06	$2.74	$2.53	$1.85
Shares
Basic Shares Outstanding	34.1M	32.7M	29.1M	25.9M	24.6M
Diluted Shares Outstanding	34.1M	32.7M	29.1M	25.9M	24.6M
Profitability Metrics
EBITDA	(12.3M)	(12.1M)	(16.6M)	(22.8M)	(36.6M)
D&A	1.2M	1.9M	1.8M	1.6M	3.0M
EBIT	(13.5M)	(14.0M)	(18.3M)	(24.4M)	(39.6M)

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026